dc.contributor.author | Smith, Timothy Andrew Davies | |
dc.contributor.author | Simpson, Michael | |
dc.contributor.author | Cheyne, Richard William | |
dc.contributor.author | Trembleau, Laurent Alain Claude | |
dc.date.accessioned | 2013-03-01T12:45:00Z | |
dc.date.available | 2013-03-01T12:45:00Z | |
dc.date.issued | 2011-10 | |
dc.identifier | 4539350 | |
dc.identifier | 410fa3fc-cc46-460c-9b34-602ec1c47491 | |
dc.identifier | 79960958959 | |
dc.identifier.citation | Smith , T A D , Simpson , M , Cheyne , R W & Trembleau , L A C 2011 , ' 18F-PEG-biotin : Precursor (boroaryl-PEG-biotin) synthesis, 18F-labelling and an in-vitro assessment of its binding to NeutravidinTM -trastuzumab pre-treated cells ' , Applied Radiation and Isotopes , vol. 69 , no. 10 , pp. 1395-1400 . https://doi.org/10.1016/j.apradiso.2011.05.005 | en |
dc.identifier.issn | 0969-8043 | |
dc.identifier.other | ORCID: /0000-0001-6376-9077/work/72631845 | |
dc.identifier.uri | http://hdl.handle.net/2164/2684 | |
dc.format.extent | 6 | |
dc.format.extent | 207872 | |
dc.language.iso | eng | |
dc.relation.ispartof | Applied Radiation and Isotopes | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | 18F | en |
dc.subject | PET | en |
dc.subject | Neutravidin™ | en |
dc.subject | breast cancer cells | en |
dc.subject | Biotin | en |
dc.subject | QD Chemistry | en |
dc.subject.lcc | QD | en |
dc.title | 18F-PEG-biotin : Precursor (boroaryl-PEG-biotin) synthesis, 18F-labelling and an in-vitro assessment of its binding to NeutravidinTM -trastuzumab pre-treated cells | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Chemistry | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1016/j.apradiso.2011.05.005 | |